Pexelizumab, an Anti-C5 Complement Antibody for Primary Coronary Revascularization: A New Insight from Old Versions. [electronic resource]
Producer: 20160519Description: 97-101 p. digitalISSN:- 2212-4063
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.